Trial intelligence / Profile preview

Simvastatin in acute lung injury and acute respiratory distress syndrome

2006-001414-33Phase 4Completed

Sponsor
Royal Group of Hospitals
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of simvastatin in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Royal Group of Hospitals. Primary endpoint: Reduction in extravascular lung water at day 7. Started Jul 2007; status: completed.

02

Drugs

simvastatin
03

Conditions

acute lung injury (ALI)acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on 2006-001414-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001414-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call